Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention

Non-steroidal anti-inflammatory drugs (NSAIDs) exhibit anti-neoplastic (chemoprevention) activity for sporadic cancers and the hereditary cancer predisposition Lynch syndrome (LS/HNPCC). However, the mechanism of NSAID tumor suppression has remained enigmatic. Defects in the core mismatch repair (MM...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-López, Juana, Gasparini, Pierluigi, Coombes, Kevin, Croce, Carlo M., Boivin, Gregory P., Fishel, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849154/
https://www.ncbi.nlm.nih.gov/pubmed/29560090
http://dx.doi.org/10.18632/oncotarget.23792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849154/
https://www.ncbi.nlm.nih.gov/pubmed/29560090
http://dx.doi.org/10.18632/oncotarget.23792

Ejemplares similares